GASC1 expression in lung carcinoma is associated with smoking and prognosis of squamous cell carcinoma

Histology and Histopathology

Volumn 29, Issue 6, 2014, Pages 797-804

  Uimonen, Katri ^a,b   Merikallio, Heta ^c   Pääkkö, Paavo ^d   Harju, Terttu ^c   Mannermaa, Arto ^a,b   Palvimo, Jorma ^a   Kosma, Veli Matti ^a,b   Soini, Ylermi ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Epigenetics; GASC1; Histone demethylase; Lung cancer

Indexed keywords

HISTONE DEMETHYLASE; KDM4C PROTEIN, HUMAN;

ADENOCARCINOMA; AGED; FEMALE; GENETIC EPIGENESIS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SMOKING; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; EPIGENESIS, GENETIC; FEMALE; GENE-ENVIRONMENT INTERACTION; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SMOKING;

EID: 84899749715     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Broeks A., Schmidt M.K., Sherman M.E., Couch F.J., Hopper J.L., Dite G.S., Apicella C., Smith L.D., Hammet F., Southey M.C., Van 't Veer L.J., de Groot R., Smit V.T., Fasching P.A., Beckmann M.W., Jud S., Ekici A.B., Hartmann A., Hein A., Schulz-Wendtland R., Burwinkel B., Marme F., Schneeweiss A., Sinn H.P., Sohn C., Tchatchou S., Bojesen S.E., Nordestgaard B.G., Flyger H., Ørsted D.D., Kaur-Knudsen D., Milne R.L., Pérez J.I., Zamora P., Rodríguez P.M., Benítez J., Brauch H., Justenhoven C., Ko Y.D.; Genica Network, Hamann U., Fischer H.P., Brüning T., Pesch B., Chang-Claude J., Wang-Gohrke S., Bremer M., Karstens J.H., Hillemanns P., Dörk T., Nevanlinna H.A., Heikkinen T., Heikkilä P., Blomqvist C., Aittomäki K., Aaltonen K., Lindblom A., Margolin S., Mannermaa A., Kosma V.M., Kauppinen J.M., Kataja V., Auvinen P., Eskelinen M., Soini Y., Chenevix-Trench G., Spurdle A.B., Beesley J., Chen X., Holland H.; kConFab; AOCS, Lambrechts D., Claes B., Vandorpe T., Neven P., Wildiers H., Flesch-Janys D., Hein R., Löning T., Kosel M., Fredericksen Z.S., Wang X., Giles G.G., Baglietto L., Severi G., McLean C., Haiman C.A., Henderson B.E., Le Marchand L., Kolonel L.N., Alnæs G.G., Kristensen V., Børresen-Dale A.L., Hunter D.J., Hankinson S.E., Andrulis I.L., Mulligan A.M., O'Malley F.P., Devilee P., Huijts P.E., Tollenaar R.A., Van Asperen C.J., Seynaeve C.S., Chanock S.J., Lissowska J., Brinton L., Peplonska B., Figueroa J., Yang X.R., Hooning M.J., Hollestelle A., Oldenburg R.A., Jager A., Kriege M., Ozturk B., van Leenders G.J., Hall P., Czene K., Humphreys K., Liu J., Cox A., Connley D., Cramp H.E., Cross S.S., Balasubramanian S.P., Reed M.W., Dunning A.M., Easton D.F., Humphreys M.K., Caldas C., Blows F., Driver K., Provenzano E., Lubinski J., Jakubowska A., Huzarski T., Byrski T., Cybulski C., Gorski B., Gronwald J., Brennan P., Sangrajrang S., Gaborieau V., Shen C.Y., Hsiung C.N., Yu J.C., Chen S.T., Hsu G.C., Hou M.F., Huang C.S., Anton-Culver H., Ziogas A., Pharoah P.D. and Garcia-Closas M. (2011). Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 20, 3289-3303.
2. Canova C., Hashibe M., Simonato L., Nelis M., Metspalu A., Lagiou P., Trichopoulos D., Ahrens W., Pigeot I., Merletti F., Richiardi L., Talamini R., Barzan L., Macfarlane G.J., Macfarlane T.V., Holcatova I., Bencko V., Benhamou S., Bouchardy C., Kjaerheim K., Lowry R., Agudo A., Castellsague X., Conway D.I., McKinney P.A., Znaor A., McCartan B.E., Healy C.M., Marron M. and Brennan P. (2009). Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res. 69, 2956-2965.
3. Cloos P.A., Christensen J., Agger K., Maiolica A., Rappsilber J., Antal T., Hansen K.H. and Helin K. (2006). The putative oncogene GASC1 demethylates tri-and dimethylated lysine 9 on histone H3. Nature 442, 307-311.
4. Ishimura A., Terashima M., Kimura H., Akagi K., Suzuki Y., Sugano S. and Suzuki T. (2009). Jmjd2c histone demethylase enhances the expression of Mdm2 oncogene. Biochem. Biophys. Res. Commun. 389, 366-371.
5. Kan Z., Jaiswal B.S., Stinson J., Janakiraman V., Bhatt D., Stern H.M., Yue P., Haverty P.M., Bourgon R., Zheng J., Moorhead M., Chaudhuri S., Tomsho L.P., Peters B.A., Pujara K., Cordes S., Davis D.P., Carlton V.E., Yuan W., Li L., Wang W., Eigenbrot C., Kaminker J.S., Eberhard D.A., Waring P., Schuster S.C., Modrusan Z., Zhang Z., Stokoe D., de Sauvage F.J., Faham M. and Seshagiri S. (2010). Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869-873.
6. Klose R.J. and Zhang Y. (2007). Regulation of histone methylation by demethylimination and demethylation. Nature Rev. Mol. Cell. Biol. 8, 307-318.
7. Liu G., Bollig-Fischer A., Kreike B., van de Vijver M.J., Abrams J., Ethier S.P. and Yang Z.Q. (2009). Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene 28, 4491-4500.
8. Mitsudomi T., Kosaka T. and Yatabe Y. (2006). Biological and clinical implications of EGFR mutations in lung cancer. Int. J. Clin. Oncol. 11, 190-198.
9. Northcott P.A., Nakahara Y., Wu X., Feuk L., Ellison D.W., Croul S., Mack S., Kongkham P.N., Peacock J., Dubuc A., Ra Y.S., Zilberberg K., McLeod J., Scherer S.W., Sunil Rao J., Eberhart C.G., Grajkowska W., Gillespie Y., Lach B., Grundy R., Pollack I.F., Hamilton R.L., Van Meter T., Carlotti C.G., Boop F., Bigner D., Gilbertson R.J., Rutka J.T. and Taylor M.D. (2009). Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat. Genet. 41, 465-472.
10. Pillai R.N. and Ramalingam S.S. (2012). The biology and clinical features of non-smal l cel l lung cancers with EML4-ALK translocation. Cur. Oncol. Rep. 14, 105-110.
11. Scoccianti C., Vesin A., Martel G., Olivier M., Brambilla E., Timsit J.F., the EUELC Consortium, Tavecchio L., Brambilla C., Field J.K. and Hainaut P. (2012). Prognostic value of TP53, KRAS and EGFR mutations in Non-Small Cell Lung Cancer: EUELC cohort. Eur. Respir. J. 40, 177-184
12. Shi Y. and Whetstine J.R. (2007). Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 25, 1-14.
13. Shin S. and Janknecht R. (2007). Diversity within the JMJD2 histone demethylase family. Biochem. Biophys. Res. Commun. 353, 973-977.
14. Steele-Perkins G., Fang W., Yang X.H., Van Gele M., Carling T., Gu J., Buyse I.M., Fletcher J.A., Liu J., Bronson R., Chadwick R.B., de la Chapelle A., Zhang X., Speleman F. and Huang S. (2001). Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev. 15, 2250-2262.
15. Suikki H.E., Kujala P.M., Tammela T.L., van Weerden W.M., Vessella R.L. and Visakorpi T. (2010). Genetic alterations and changes in expression of histone demethylases in prostate cancer. Prostate 70, 889-898
16. Travis W.D., Brambilla E., Muller-Hermelink H.K. and Harris C.C. (2004). Tumours of the lung, pleura, thymus and heart. Pathology & genetics. WHO classification of tumours, IARC Press, Lyon.
17. Wang J., Zhang M., Zhang Y., Kou Z., Han Z., Chen D.Y., Sun Q.Y. and Gao S. (2010). The histone demethylase JMJD2C is stagespecifically expressed in preimplantation mouse embryos and is required for embryonic development. Biol. Reprod. 82, 105-111.
18. Whetstine J.R., Nottke A., Lan F., Huarte M., Smolikov S., Chen Z., Spooner E., Li E., Zhang G., Colaiacovo M. and Shi Y. (2006). Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125, 467-481.
19. Wissmann M., Yin N., Muller J.M., Greschik H., Fodor B.D., Jenuwein T., Vogler C., Schneider R., Günther T., Buettner R., Metzger E. and Schüle R. (2007). Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell. Biol. 9, 347-53.
20. Yang Z.Q., Imoto I., Fukuda Y., Pimkhaokham A., Shimada Y., Imamura M., Sugano S., Nakamura Y. and Inazawa J. (2000). Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res. 60, 4735-4739.